Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's Macroglobulinemia

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 69; no. 8; pp. 3579 - 3588
Main Authors BRAGGIO, Esteban, KEATS, Jonathan J, AZAB, Feda, GREIPP, Philip, GERTZ, Morie, HAYMAN, Suzanne, RAJKUMAR, S. Vincent, CARPTEN, John, CHEST, Marta, BARRETT, Michael, STEWART, A. Keith, DOGAN, Ahmet, LELEU, Xavier, LEIF BERGSAGEL, P, GHOBRIAL, Irene M, FONSECA, Rafael, VAN WIER, Scott, JIMENEZ-ZEPEDA, Victor H, VALDEZ, Riccardo, SCHOP, Roelandt F. J, PRICE-TROSKA, Tammy, HENDERSON, Kimberly, SACCO, Antonio
Format Journal Article
LanguageEnglish
Published Philadelphia, PA American Association for Cancer Research 15.04.2009
Subjects
Antineoplastic agents
Biological and medical sciences
Hematologic and hematopoietic diseases
Immunodeficiencies. Immunoglobulinopathies
Immunoglobulinopathies
Immunopathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Medical sciences
Pharmacology. Drug treatments
Tumors
Immunopathology
Copy number
Malignant hemopathy
Identification
Regulator
Waldenström macroglobulinemia
Signal transduction
Immunoglobulinopathy
Signaling pathway
Lymphoproliferative syndrome
Genetics
Transcription factor NFκB
Mutation
Cancer
Online AccessGet full text

Cover

More Information
ISSN:0008-5472
1538-7445
DOI:10.1158/0008-5472.CAN-08-3701